Symphony Environmental believe Meditech deal will go commercial in a very big way during 2022 (LON:SYM)
Symphony Environmental’s Michael Laurier discusses equity injection from Vincel Investment Holdings, huge market in the US for d2p, approval from Health Canada and thoughts for the future in this exclusive interview with DirectorsTalk.